FindTrial
Sign In

prospective randomized controlled trial of RATS vs. standard thoractomy for N2 NSCLC patients

prospective randomized controlled trial of RATS vs. standard thoractomy for N2 NSCLC patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17012777
Enrollment
Unknown
Registered
2017-09-23
Start date
2017-09-25
Completion date
Unknown
Last updated
2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

RATS:robotic surgery
open:open surgery

Sponsors

Shanghai Chest hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. NSCLC patients; 2. aged 18-75 years old; 3. diagnosed with clinical N2 stage via enhanced chest CT presented enlarged mediastinal lymph node (>1cm) andd/or PET-CT and/or EBUS and/or mediastinoscopy; 4. Karnofsky>80; 5. has the ability to tolerate operation; 6. to be able to understand and stick to the rules and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. with previous or concurrent malignant tumor; 2. with distant metastasis; 3. pregnant or lactating women; 4. severe organic disease; 5. can not stand the surgery; 6. can not complete the treatmen plan.

Design outcomes

Primary

MeasureTime frame
5-year overall survival;—

Secondary

MeasureTime frame
pain degree;—

Countries

China

Contacts

Public ContactLuo Qingquan

Shanghai Chest Hospital

huangjiadragon@126.com+86 18017320257

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026